Atlas Trials

A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma

Clinical trial NCT02156648 · UNKNOWN

Trial details

NCT number
NCT02156648
Sponsor
Ottawa Hospital Research Institute
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-08-01
Primary completion
2020-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.